文献速递消化道肿瘤与早癌

维生素D状态与巴雷特食管或食管腺癌风险无关联:一项孟德尔随机化研究

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-02-01

该研究采用两样本孟德尔随机化方法,以6个与循环25羟维生素D浓度相关的单核苷酸多态性作为工具变量,纳入6167例巴雷特食管患者、4112例食管腺癌患者和17159名对照,未发现遗传估计的25羟维生素D浓度与巴雷特食管或食管腺癌风险存在关联。

要点

  • 遗传估计的25羟维生素D浓度每升高20 nmol/L,巴雷特食管风险的OR为1.21(95%CI 0.77-1.92;P=0.41)。
  • 遗传估计的25羟维生素D浓度每升高20 nmol/L,食管腺癌风险的OR为0.68(95%CI 0.39-1.19;P=0.18)。
  • 孟德尔随机化分析未发现低遗传估计25羟维生素D浓度与巴雷特食管或食管腺癌风险相关。

核心结论

  • 在一项孟德尔随机化研究中,未发现遗传估计的低25羟维生素D浓度与巴雷特食管或食管腺癌风险相关。

研究设计与样本

  • 采用两样本(汇总数据)孟德尔随机化研究设计。
  • 以6个与循环25羟维生素D浓度相关的单核苷酸多态性(rs3755967、rs10741657、rs12785878、rs10745742、rs8018720和rs17216707)作为工具变量。
  • 数据来自巴雷特食管与食管腺癌联盟的6167例巴雷特食管患者、4112例食管腺癌患者和17159名无巴雷特食管或食管腺癌的对照,以及来自德国波恩和英国剑桥、牛津的研究。
  • 分析分别针对巴雷特食管和食管腺癌进行。

主要发现

  • 采用逆方差加权法合并单个SNP关联后,遗传估计的25羟维生素D浓度每升高20 nmol/L,巴雷特食管风险的OR为1.21(95%CI 0.77-1.92;P=0.41)。
  • 采用逆方差加权法合并单个SNP关联后,食管腺癌风险的OR为0.68(95%CI 0.39-1.19;P=0.18)。
  • 总体未发现遗传估计的25羟维生素D浓度与巴雷特食管或食管腺癌风险存在关联的证据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study to determine the associations between circulating concentrations of 25(OH)D and risks of EAC and its precursor, Barrett's esophagus (BE). METHODS: We conducted a Mendelian randomization study using a 2-sample (summary data) approach. Six single-nucleotide polymorphisms (SNPs; rs3755967, rs10741657, rs12785878, rs10745742, rs8018720, and rs17216707) associated with circulating concentrations of 25(OH)D were used as instrumental variables. We collected data from 6167 patients with BE, 4112 patients with EAC, and 17,159 individuals without BE or EAC (controls) participating in the Barrett's and Esophageal Adenocarcinoma Consortium, as well as studies from Bonn, Germany, and Cambridge and Oxford, United Kingdom. Analyses were performed separately for BE and EAC. RESULTS: Overall, we found no evidence for an association between genetically estimated 25(OH)D concentration and risk of BE or EAC. The odds ratio per 20 nmol/L increase in genetically estimated 25(OH)D concentration for BE risk estimated by combining the individual SNP association using inverse variance weighting was 1.21 (95% CI, 0.77-1.92; P = .41). The odds ratio for EAC risk, estimated by combining the individual SNP association using inverse variance weighting, was 0.68 (95% CI, 0.39-1.19; P = .18). CONCLUSIONS: In a Mendelian randomization study, we found that low genetically estimated 25(OH)D concentrations were not associated with risk of BE or EAC.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Dong J, Gharahkhani P, Chow WH, et al. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. Clin Gastroenterol Hepatol. 2019. PMID: 30716477. doi:10.1016/j.cgh.2019.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。